Datavault AI Inc. (NASDAQ: DVLT) has expanded its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS) to extend its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan and wellness applications. The expanded relationship is designed to support patient-controlled health data access, monetization and real-world asset tokenization across pharmacy, medical, laboratory and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health and AI-driven remote patient monitoring.
Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS’ outstanding common stock upon closing of previously announced related transactions, replacing the preferred shares originally contemplated for tax optimization purposes. The companies said the agreement accelerates deployment of Datavault AI’s technology into the healthcare sector, targeting opportunities within the rapidly expanding global health and wellness market while enabling new patient-controlled data transaction models.
This expansion is significant because it marks the entry of Datavault AI’s blockchain and AI technologies into the commercial healthcare sector, a market with substantial growth potential. By enabling patients to control and monetize their own health data, the partnership addresses growing concerns about data privacy and security while creating new revenue streams. The integration of real-world asset tokenization could also facilitate new business models in healthcare, such as tokenized health records or wearable device data markets.
Datavault AI is a leader in AI-driven data experiences, valuation and monetization of assets in the Web 3.0 environment. Its cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions. The Data Science division leverages Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. The company’s technology serves multiple industries, including healthcare, through its Information Data Exchange, which enables Digital Twins and secure attachment of physical objects to immutable metadata.
The partnership with DataMEDS is expected to drive adoption of Datavault AI’s technologies in healthcare, potentially leading to broader industry acceptance of blockchain-based patient data management. As the global health and wellness market expands, the ability to securely manage and monetize patient data becomes increasingly valuable. This agreement positions both companies to capitalize on these trends.
For more information, visit Datavault AI and see the full press release here.
